chr8-15743653-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_006765.4(TUSC3):c.937+41C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0113 in 1,599,688 control chromosomes in the GnomAD database, including 181 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0098 ( 9 hom., cov: 33)
Exomes 𝑓: 0.011 ( 172 hom. )
Consequence
TUSC3
NM_006765.4 intron
NM_006765.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.905
Publications
3 publications found
Genes affected
TUSC3 (HGNC:30242): (tumor suppressor candidate 3) This gene encodes a protein that has been associated with several biological functions including cellular magnesium uptake, protein glycosylation and embryonic development. This protein localizes to the endoplasmic reticulum and acts as a component of the oligosaccharyl transferase complex which is responsible for N-linked protein glycosylation. This gene is a candidate tumor suppressor gene. Homozygous mutations in this gene are associated with autosomal recessive nonsyndromic mental retardation-7 and in the proliferation and invasiveness of several cancers including metastatic pancreatic cancer, ovarian cancer and glioblastoma multiform. [provided by RefSeq, Oct 2017]
TUSC3 Gene-Disease associations (from GenCC):
- intellectual disabilityInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- intellectual disability, autosomal recessive 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- autosomal recessive non-syndromic intellectual disabilityInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 8-15743653-C-G is Benign according to our data. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-15743653-C-G is described in CliVar as Likely_benign. Clinvar id is 1187727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0098 (1491/152204) while in subpopulation SAS AF = 0.0249 (120/4810). AF 95% confidence interval is 0.0213. There are 9 homozygotes in GnomAd4. There are 722 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00980 AC: 1490AN: 152086Hom.: 9 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1490
AN:
152086
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0147 AC: 3675AN: 249528 AF XY: 0.0164 show subpopulations
GnomAD2 exomes
AF:
AC:
3675
AN:
249528
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0114 AC: 16533AN: 1447484Hom.: 172 Cov.: 27 AF XY: 0.0124 AC XY: 8918AN XY: 720902 show subpopulations
GnomAD4 exome
AF:
AC:
16533
AN:
1447484
Hom.:
Cov.:
27
AF XY:
AC XY:
8918
AN XY:
720902
show subpopulations
African (AFR)
AF:
AC:
80
AN:
33122
American (AMR)
AF:
AC:
370
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
AC:
1030
AN:
26048
East Asian (EAS)
AF:
AC:
639
AN:
39598
South Asian (SAS)
AF:
AC:
2804
AN:
85930
European-Finnish (FIN)
AF:
AC:
347
AN:
53294
Middle Eastern (MID)
AF:
AC:
186
AN:
5732
European-Non Finnish (NFE)
AF:
AC:
10300
AN:
1099152
Other (OTH)
AF:
AC:
777
AN:
59904
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
915
1830
2745
3660
4575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
410
820
1230
1640
2050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00980 AC: 1491AN: 152204Hom.: 9 Cov.: 33 AF XY: 0.00970 AC XY: 722AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
1491
AN:
152204
Hom.:
Cov.:
33
AF XY:
AC XY:
722
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
97
AN:
41530
American (AMR)
AF:
AC:
201
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
129
AN:
3470
East Asian (EAS)
AF:
AC:
98
AN:
5180
South Asian (SAS)
AF:
AC:
120
AN:
4810
European-Finnish (FIN)
AF:
AC:
73
AN:
10590
Middle Eastern (MID)
AF:
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
AC:
716
AN:
68020
Other (OTH)
AF:
AC:
35
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
80
161
241
322
402
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
51
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Sep 06, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.